Royce & Associates’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-120,457
| Closed | -$3.95M | – | 995 |
|
|
2022
Q2 | $3.95M | Sell |
120,457
-240,401
| -67% | -$7.88M | 0.04% | 543 |
|
|
2022
Q1 | $9.48M | Buy |
360,858
+86,399
| +31% | +$2.27M | 0.08% | 380 |
|
|
2021
Q4 | $6.51M | Buy |
274,459
+94,194
| +52% | +$2.24M | 0.05% | 503 |
|
|
2021
Q3 | $4.52M | Sell |
180,265
-2,137
| -1% | -$53.6K | 0.03% | 604 |
|
|
2021
Q2 | $4.74M | Sell |
182,402
-6,318
| -3% | -$164K | 0.03% | 612 |
|
|
2021
Q1 | $4.83M | Buy |
188,720
+82,625
| +78% | +$2.12M | 0.03% | 606 |
|
|
2020
Q4 | $2.13M | Buy |
106,095
+1,335
| +1% | +$26.8K | 0.02% | 710 |
|
|
2020
Q3 | $1.8M | Buy |
104,760
+33,258
| +47% | +$570K | 0.02% | 699 |
|
|
2020
Q2 | $1.56M | Buy |
71,502
+70,213
| +5,447% | +$1.53M | 0.02% | 716 |
|
|
2020
Q1 | $30K | Buy |
1,289
+16
| +1% | +$372 | ﹤0.01% | 1069 |
|
|
2019
Q4 | $42K | Sell |
1,273
-146
| -10% | -$4.82K | ﹤0.01% | 1058 |
|
|
2019
Q3 | $45K | Buy |
1,419
+340
| +32% | +$10.8K | ﹤0.01% | 1060 |
|
|
2019
Q2 | $28K | Sell |
1,079
-21
| -2% | -$545 | ﹤0.01% | 1088 |
|
|
2019
Q1 | $28K | Buy |
1,100
+392
| +55% | +$9.98K | ﹤0.01% | 1103 |
|
|
2018
Q4 | $24K | Sell |
708
-36
| -5% | -$1.22K | ﹤0.01% | 1078 |
|
|
2018
Q3 | $27K | Buy |
744
+278
| +60% | +$10.1K | ﹤0.01% | 1126 |
|
|
2018
Q2 | $16K | Buy |
466
+172
| +59% | +$5.91K | ﹤0.01% | 1172 |
|
|
2018
Q1 | $10K | Buy |
294
+46
| +19% | +$1.57K | ﹤0.01% | 1187 |
|
|
2017
Q4 | $9K | Sell |
248
-3
| -1% | -$109 | ﹤0.01% | 1200 |
|
|
2017
Q3 | $9K | Buy |
+251
| New | +$9K | ﹤0.01% | 1183 |
|
|
2014
Q2 | – | Sell |
-2,100
| Closed | -$54K | – | 1466 |
|
|
2014
Q1 | $54K | Buy |
+2,100
| New | +$54K | ﹤0.01% | 1372 |
|